Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


29 April, 2020

Updates and announcements

Hyris Ltd on Immunological Reviews - Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment


We are proud of our last result, a publication on Immunological Reviews of the paper “Application of a portable instrument for rapid and reliable detection of SARS-CoV-2 infection in any environment”.

The realization of this publication represents a milestone and praise the inestimable contributes of two important researcher: Dr. Federico Martinelli (Department of Biology, Università degli studi di Firenze, Firenze, Italy) and Dr. Anna Perrone (Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy) .

The article evaluates the pandemic we’re living and the screening methodologies available at the moment proposing the bCUBE as a viable alternative for a quick and simple detection of this virus in humans.

FULL ARTICLE HERE